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There is a worldwide emphasis on preventing overdiagnosis 
of disease. Overdiagnosis is defined as the diagnosis of a 
disease or condition that is unlikely to ever cause harm.
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Overdiagnosis is a huge problem which has serious 
consequences for the patients as well as health care system. 
For the patients, these include unnecessary treatment with 
consequent adverse effects and unnecessary monetary 
burden, as well as the psychological trauma. For health care 
system, it causes waste of precious resources and unduly 
increased work load for the health professionals. Such is the 
global concern for this problem that since 2013, health 
professionals from all around the world gather for 
“Preventing Overdiagnosis” conference, held every year. 
Cancer overdiagnosis has a much greater potential for harm 
due to its enormous psychological trauma, arduous treatment 
protocol, rife with life threatening complications and 
staggering cost for the patient and healthcare system.
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As a result, work is ongoing in various fields to identify 
cancers which have excellent prognosis and have shown to 
have an indolent disease-free course, with prolonged clinical 
trials. One such success story is recent revision of 
nomenclature for „Encapsulated Follicular Variant of 
Papillary Thyroid Carcinoma (EFVPTC).” For a long time, 
it was felt that EFVPTC has a much more indolent behavior 
than its infiltrative counterpart. But traditionally, all tumors 
with characteristic nuclear features of papillary thyroid 
carcinoma (PTC) were designated as carcinomas and treated 
as such. To address this issue, an international panel of 
expert pathologists and clinicians from around the world 
were assembled to review a set of cases with adequately 
long follow-up, to see if this group can be re-classified 
according to its behavior.
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The Endocrine Pathology Society working group, 
comprising of 24 experienced thyroid pathologists from 7 
countries, reviewed 268 cases of EFVPTC. These cases 
were divided into 2 groups, those with capsular or vascular 
invasion and those showing no invasion. The results of this 
study showed that patients with noninvasive EFVPTC, 
followed up for a median period of 13 years, were all alive 
and disease-free despite the fact that majority of these 
patients did not undergo total thyroidectomy and none 
received radioactive iodine (RAI). The study recommended 
that this group of cases should not be designated as 
“carcinoma” and proposed the term, “noninvasive follicular 
thyroid neoplasms with papillary-like nuclear features” 
(NIFTP).
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 The study and its recommendations have been 
hailed around the world as a step in the right direction. Most 
centers dealing with thyroid cancer cases are now using this 
terminology and have modified their treatment protocols. It 
is however imperative that this diagnosis should only be 
rendered after extensive, preferably entire / complete 
sampling of the capsule, to rule out any focus of invasion. 
An important related issue, not directly addressed in this 
study, is the diagnosis of these lesions on Fine Needle 
Aspiration (FNA) cytology. Traditionally, on FNA cytology, 
lesions showing cells with characteristic nuclear features of 
PTC, but with follicle formation without any papillary 
structures, were diagnosed as follicular variant of papillary 
thyroid carcinoma or suspicious for malignancy, since they 
were considered as carcinoma whether they were invasive or 
noninvasive. But now, since it has been established that this 
group termed NIFTP is not malignant, such lesions on FNA 
should be labeled as suspicious for malignancy or follicular 
neoplasm/suspicious for a follicular neoplasm
4
 with a 
comment that differential diagnosis includes FVPTC, 
EFVPTC and NIFTP. This important development will 
hopefully further invigorate efforts to identify cancers which 
are being over diagnosed and to re-classify them, in order to 
remove the psychological stigma, and to reduce treatment 
related adverse effects and medical expenses. 
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